Isofol Medical: Patent portfolio strengthened
Isofol Medical announced this morning that a patent has been approved in the USA, strengthening the patent protection for arfolitixorin significantly. The patent covers the active pharmaceutical ingredient (API), the drug product and the finalised solution that is administered to patients.